Sweden
· Delayed Price · Currency is SEK Vaxxa AB Statistics
Total Valuation
Vaxxa AB has a market cap or net worth of SEK 43.30 million. The enterprise value is 33.71 million.
| Market Cap | 43.30M |
| Enterprise Value | 33.71M |
Important Dates
The next estimated earnings date is Friday, October 25, 2024.
| Earnings Date | Oct 25, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Vaxxa AB has 33.31 million shares outstanding. The number of shares has increased by 2,258.65% in one year.
| Shares Outstanding | 33.31M |
| Shares Change (YoY) | +2,258.65% |
| Shares Change (QoQ) | +29.04% |
| Owned by Insiders (%) | 2.08% |
| Owned by Institutions (%) | n/a |
| Float | 32.61M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.65 |
| PB Ratio | 2.49 |
| P/FCF Ratio | 58.75 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.39, with an EV/FCF ratio of 45.74.
| EV / Earnings | -60.53 |
| EV / Sales | 0.41 |
| EV / EBITDA | 10.39 |
| EV / EBIT | n/a |
| EV / FCF | 45.74 |
Financial Position
The company has a current ratio of 2.70, with a Debt / Equity ratio of 4.66.
| Current Ratio | 2.70 |
| Quick Ratio | 2.64 |
| Debt / Equity | 4.66 |
| Debt / EBITDA | 0.25 |
| Debt / FCF | 1.10 |
| Interest Coverage | -0.52 |
Financial Efficiency
Return on equity (ROE) is -4.97% and return on invested capital (ROIC) is -0.93%.
| Return on Equity (ROE) | -4.97% |
| Return on Assets (ROA) | -0.65% |
| Return on Capital (ROIC) | -0.93% |
| Revenue Per Employee | 11.68M |
| Profits Per Employee | -79,571 |
| Employee Count | 4 |
| Asset Turnover | 4.35 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +62.50% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +62.50% |
| 50-Day Moving Average | 1.10 |
| 200-Day Moving Average | 0.94 |
| Relative Strength Index (RSI) | 55.67 |
| Average Volume (20 Days) | 86,626 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Vaxxa AB had revenue of SEK 81.76 million and -557,000 in losses. Loss per share was -0.01.
| Revenue | 81.76M |
| Gross Profit | 7.41M |
| Operating Income | -195,000 |
| Pretax Income | -557,000 |
| Net Income | -557,000 |
| EBITDA | 3.25M |
| EBIT | -195,000 |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 10.40 million in cash and 811,000 in debt, giving a net cash position of 9.58 million or 0.29 per share.
| Cash & Cash Equivalents | 10.40M |
| Total Debt | 811,000 |
| Net Cash | 9.58M |
| Net Cash Per Share | 0.29 |
| Equity (Book Value) | 17.40M |
| Book Value Per Share | 0.52 |
| Working Capital | 7.20M |
Cash Flow
In the last 12 months, operating cash flow was 1.67 million and capital expenditures -933,000, giving a free cash flow of 737,000.
| Operating Cash Flow | 1.67M |
| Capital Expenditures | -933,000 |
| Free Cash Flow | 737,000 |
| FCF Per Share | 0.02 |
Margins
Gross margin is 9.06%, with operating and profit margins of -0.24% and -0.68%.
| Gross Margin | 9.06% |
| Operating Margin | -0.24% |
| Pretax Margin | -0.68% |
| Profit Margin | -0.68% |
| EBITDA Margin | 3.97% |
| EBIT Margin | -0.24% |
| FCF Margin | 0.90% |
Dividends & Yields
Vaxxa AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2,258.65% |
| Shareholder Yield | -2,258.65% |
| Earnings Yield | -1.05% |
| FCF Yield | 1.70% |
Stock Splits
The last stock split was on March 14, 2024. It was a reverse split with a ratio of 0.01.
| Last Split Date | Mar 14, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.01 |